跳至主要内容
临床试验/NCT02084537
NCT02084537已完成不适用

Minimally Invasive Surgery vs. Endoscopy Randomized (MISER) Trial for Necrotizing Pancreatitis

AdventHealth2 个研究点 分布在 1 个国家目标入组 69 人开始时间: 2014年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AdventHealth
入组人数
69
试验地点
2
主要终点
Major complications

研究概览

简要总结

Prospective, randomized controlled trial comparing Endoscopic Ultrasound (EUS) Guided cystogastrostomy or cystoduodenostomy and endoscopic necrosectomy to minimally invasive surgical necrosectomy, in patients with necrotizing pancreatitis.

详细描述

Patients will be randomly allocated to either treatment arm in a 1:1 ratio. Following intervention, patients will be assessed at regular intervals until study completion at 6 months post-discharge. Primary outcome is a composite of major complications and/or mortality, measured to 6 months post-discharge.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Necrotic collection
  • Infected (suspected and confirmed): clinical signs of infection (septic, positive cultures, febrile), systemic inflammatory response syndrome, gas within the collection on imaging (not iatrogenic), or positive culture of collection contents
  • Necrotic collection is within 15mm of the lumen of the gastrointestinal tract.
  • 18 years and older
  • Informed consent obtained from the patient or their medical representative.
  • Medically fit for general anesthetic
  • Collection amenable to either endoscopic or minimally invasive surgical necrosectomy and drainage.

排除标准

  • <18 years old
  • Unable to obtain informed consent from the patient or their medical representative.
  • Medically unfit for general anesthesia
  • Necrotic collection not accessible by either or both techniques
  • The collection is >15mm from the lumen of the gastrointestinal tract.
  • Irreversible coagulopathy: International Normalized Ratio (INR) >1.5
  • Irreversible thrombocytopenia: platelet count <50 x10^9/L
  • Dual antiplatelet therapy or therapeutic anticoagulation that cannot be withheld for the procedure
  • Surgical or endoscopic necrosectomy or pseudocyst drainage has been performed within the preceding 12 months
  • Necrotic collection secondary to trauma or other surgical event that requires additional interventions such as management of liver lacerations or vascular injury.
  • Pre-existing percutaneous drain

结局指标

主要结局

Major complications

时间窗: 6 months post discharge

Composite of major complications and/or mortality (all cause and disease specific), measured to 6 months post discharge

次要结局

未报告次要终点

研究者

发起方
AdventHealth
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验